Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04181008 · ClinicalTrials.gov registry record · Early Phase 1
Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers
A Early Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT04181008 is a Early Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 15 participants.
The verdict
NCT04181008, a Early Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is a single-center, open-label study of the plasma pharmacokinetics of amiloride nasal spray at three different doses in healthy volunteers.
Interventions
- DRUG Amiloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2023-03-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04181008
The ClinicalTrials.gov registry entry for NCT04181008 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amiloride is the first listed.
NCT04181008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04181008 about?
NCT04181008 is a clinical study titled "Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers". This study is a single-center, open-label study of the plasma pharmacokinetics of amiloride nasal spray at three different doses in healthy volunteers.
What is the current status of trial NCT04181008?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2020-09-28. Estimated completion is 2023-03-06.
What interventions are being tested in trial NCT04181008?
The interventions under investigation include: Amiloride (DRUG).
Who is sponsoring clinical trial NCT04181008?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.